CARSGEN-B (02171) Announces Inclusion in Southbound Stock Connect

Bulletin Express
03/09

CARsgen Therapeutics Holdings Limited (CARSGEN-B, 02171) disclosed its inclusion in the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect, effective March 9, 2026. According to the announcement, this development allows eligible mainland Chinese investors to directly trade the company's shares through respective stock exchanges.

The announcement highlights that this inclusion signals market recognition of CARSGEN-B’s CAR-T business potential and is expected to provide mainland investors with a more convenient investment channel while enhancing market attention and liquidity. The board of directors advises shareholders and potential investors to exercise caution when dealing in the shares.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10